BEIJING,SHANGHAI and BOSTON,March 19,2025-- Jacobio Pharma (1167.HK) released its 2024 annual results,with revenue of RMB160million,R&D expense of RMB330 million. Major operating and financing act
Investment reinforces confidence in Funding Societies\' decade-long mission amid market volatility and underscores commitment to financial inclusion for underserved businesses
CRANBURY,N.J.,March 19,2025--Porton Advanced,a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs),is pleased to announce its
By integratingMedit SmartX with Imagoworks\' AOX,dental professionals can streamline the edentulous prosthetic workflow,ensuring seamless data transfer,precise prosthetic design,and enhanced restorat
CHENGDU,China,March 18,2025--On March 11,the " Weathervane Products (Spring) Global Launch," hosted by China Hongcan Network and the Hongcan Industry Research Institute,and co-organized by t
The partnership will see Iprova\'s suite of solutions integrated with IP management software IPfolio LONDON,March 18,2025--Clarivate Plc (NYSE:CLVT),a leading global provider of transformative intell
